Funding for this research was provided by:
Mayo Clinic (P50CA108961)
National Institutes of Health (R01CA114229)
Received: 4 December 2017
Accepted: 12 March 2018
First Online: 27 March 2018
Ethics approval and consent to participate
: All experimental animal procedures described in this work were reviewed and approved by the Mayo Clinic Institutional Animal Care and Use Committee (#A56814–14, “Creation, maintenance and characterization of brain tumor xenograft panel”). All research involving human tumor material was performed in accordance with the Declaration of Helsinki. Patient brain tumor samples for mouse xenograft generation were obtained with informed consent under a Mayo Clinic Institutional Review Board approved protocol (#07–007623, “Primary xenograft model for studying brain tumor biology and therapy”).
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.